NYSE:IH iHuman (IH) Stock Price, News & Analysis $1.46 +0.05 (+3.19%) Closing price 07/24/2026 03:58 PM EasternExtended Trading$1.44 -0.01 (-0.69%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock About iHuman Stock (NYSE:IH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iHuman alerts:Sign Up Key Stats Today's Range$1.41▼$1.4550-Day Range$1.35▼$1.7352-Week Range$1.33▼$3.16Volume1,781 shsAverage Volume5,747 shsMarket Capitalization$74.36 millionP/E Ratio7.66Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery. It provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China. Read More iHuman Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreIH MarketRank™: iHuman scored higher than 14% of companies evaluated by MarketBeat, and ranked 248th out of 269 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingiHuman has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageiHuman has received no research coverage in the past 90 days.Read more about iHuman's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iHuman is 7.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.04.Price to Earnings Ratio vs. SectorThe P/E ratio of iHuman is 7.66, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 19.78.Price to Book Value per Share RatioiHuman has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about iHuman's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.02% of the float of iHuman has been sold short.Short Interest Ratio / Days to CoveriHuman has a short interest ratio ("days to cover") of 0.42, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iHuman has recently increased by 61.38%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiHuman does not currently pay a dividend.Dividend GrowthiHuman does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iHuman insiders have not sold or bought any company stock.Percentage Held by Insiders63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions4.92% of the stock of iHuman is held by institutions.Read more about iHuman's insider trading history. Receive IH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IH Stock News HeadlinesiHuman Inc. Announces First Quarter 2026 Unaudited Financial ResultsJune 29, 2026 | prnewswire.comJazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic HypersomniaJune 16, 2026 | prnewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.July 25 at 1:00 AM | Banyan Hill Publishing (Ad)iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect LingoMay 31, 2026 | prnewswire.comiHuman Inc. Files 2025 Annual Report on Form 20-FApril 24, 2026 | prnewswire.comiHuman Inc. Sponsored ADR Class AApril 9, 2026 | cnn.comiHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial ResultsMarch 31, 2026 | prnewswire.comOwning 72% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's futureJanuary 15, 2026 | finance.yahoo.comSee More Headlines IH Stock Analysis - Frequently Asked Questions How have IH shares performed this year? iHuman's stock was trading at $2.1050 at the beginning of 2026. Since then, IH stock has decreased by 30.9% and is now trading at $1.4550. How were iHuman's earnings last quarter? iHuman Inc. Sponsored ADR (NYSE:IH) issued its quarterly earnings results on Monday, December, 29th. The company reported $0.06 EPS for the quarter. The firm earned $28.90 million during the quarter. iHuman had a net margin of 9.35% and a trailing twelve-month return on equity of 7.46%. When did iHuman IPO? iHuman (IH) raised $84 million in an IPO on Friday, October 9th 2020. The company issued 7,000,000 shares at a price of $11.00-$13.00 per share. Credit Suisse and Citigroup acted as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers. How do I buy shares of iHuman? Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iHuman own? Based on aggregate information from My MarketBeat watchlists, some other companies that iHuman investors own include Chevron (CVX), Baidu (BIDU), Tencent Music Entertainment Group (TME), Alibaba Group (BABA), ExxonMobil (XOM), Abbott Laboratories (ABT) and JD.com (JD). Company Calendar Last Earnings12/29/2025Record date for 5/15 Dividend4/17/2026Ex-Dividend for 5/15 Dividend4/17/2026Dividend Payable5/15/2026Today7/25/2026Next Earnings (Estimated)9/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 IH's financial health is in the Red zone, according to TradeSmith. IH has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Discretionary Industry SCHOOLS Sub-IndustryPersonal Services Current SymbolNYSE:IH CIK1814423 Webwww.ihuman.com Phone86-10-5780-6636FaxN/AEmployees1,120Year Founded2016Profitability EPS (Trailing Twelve Months)$0.19 Trailing P/E Ratio7.66 Forward P/E RatioN/A P/E GrowthN/ANet Income$13.64 million Net Margins9.35% Pretax Margin10.07% Return on Equity7.46% Return on Assets5.40% Debt Debt-to-Equity RatioN/A Current Ratio3.50 Quick Ratio3.42 Sales & Book Value Annual Sales$779.08 million Price / Sales0.10 Cash Flow$0.30 per share Price / Cash Flow4.89 Book Value$2.78 per share Price / Book0.52Miscellaneous Outstanding Shares51,108,000Free Float18,603,000Market Cap$74.36 million OptionableNot Optionable Beta0.15 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:IH) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredBlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...Awesomely | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iHuman Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share iHuman With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.